Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Epinephrine + isopropyl alcohol is a combination kit typically supplied for emergency or procedural medical use, containing injectable epinephrine solution and isopropyl alcohol swabs. Epinephrine is a synthetic catecholamine that activates alpha and beta adrenergic receptors, producing vasoconstriction, bronchodilation, increased cardiac output, and inhibition of mucosal edema. It is used to treat anaphylaxis and other acute hypersensitivity reactions, restore cardiac rhythm in cardiac arrest, provide symptomatic relief in asthma and mucosal congestion, and as an adjunct in prolonging the action of local anesthetics. Isopropyl alcohol serves as a topical antiseptic for skin disinfection prior to injection or minor procedures. No direct pharmacological interaction is expected between epinephrine and isopropyl alcohol in this kit; each component serves a separate clinical function[1][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on epinephrine + isopropyl alcohol.